Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in China

Summary

To evaluate the efficacy and safety of HSK16149 capsule in the treatment of moderate to severe central neuropathic pain compared with placebo.

Timeline

Start

2024-05-30

Primary completion

2027-07-30

Completion

2027-08-07

Publications

• Gou X, Liu Y, Ye Q, He L, Chen Y, Dong Y, Meng Q, Shi Z, Li Y, Lu Y, Wang J, Zeng L. Crisugabalin, a ligand for the alpha2delta subunit of voltage-gated calcium channels, exhibits no obvious abuse potential in rodents. Pharmacol Biochem Behav. 2025 Jul;252:174015. doi: 10.1016/j.pbb.2025.174015. Epub 2025 May 1.

Drugs

Indications